Navigation Links
Pegasys Study Authors Conclude that Patients Successfully Treated,for Hepatitis C Can be Considered ''Cured''

lowing down the growth of the virus. COPEGUS should be taken with PEGASYS to fight the virus. Do not take COPEGUS by itself.

COPEGUS (Ribavirin, USP) can be extremely harmful and cause birth defects in an unborn baby. Female patients and the female partners of male patients should avoid getting pregnant. Ribavirin is known to cause anemia (low red blood cells), which can make heart disease worse. Also, ribavirin can harm your DNA and possibly cause cancer (see medication guide for more information and warnings).

Who should not take PEGASYS and COPEGUS?

Do not take PEGASYS alone or with COPEGUS if:

-- You are pregnant or your partner is pregnant

-- You or your partner plans to get pregnant during therapy or within 6 months after treatment ends

-- You are breastfeeding

-- You have hepatitis caused by your immune system (autoimmune hepatitis)

-- You have unstable or severe liver disease before or during treatment

-- You are allergic to alpha interferons or any of the ingredients in PEGASYS and COPEGUS

-- You have abnormal red blood cells (caused by conditions like sickle-cell anemia or thalassemia major)

What if I am pregnant or thinking about having a baby?

If you are a woman who could get pregnant, you must take pregnancy tests before, during and for 6 months after treatment ends to make sure you are not pregnant.

During treatment and for 6 months after treatment, female and male patients must:

-- Use two forms of birth control (one being a condom with spermicide)

-- Tell your doctor right away if you or your partner becomes pregnant. You or your doctor should also call the Ribavirin Pregnancy Registry at 1-800-593-2214

What medication should I avoid when I am taking PEGASYS and COPEGUS?

You should not take didanosine with COPEGUS. Talk to your doctor about all medications that you are taking.

What are the possible side effects?

The mos
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Suggest that Pegasys May be an Option in Hepatitis C Patients Unable to Tolerate Peg-Intron
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
4. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
11. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility

Post Your Comments:
(Date:11/20/2009)..., , GLENWOOD, Ill., Nov. 20 /PRNewswire-Fi...ase financial results for the fiscal fourth quarte...ember 1, 2009. ,, The company will host a confe...009, at 2:00 p.m. Eastern Time. Investors may acce...he United States and Canada), or 480-629-9835 (int...
(Date:11/20/2009)..., , NEW YORK, Nov. 20 ...arch report is available in its catalogue. ,, ...tive ,, http://www.reportlinker.com/p0164373....html#utm_source=prnewswire&utm_medium=pr&...tors are treated as an integral part of any resear...
(Date:11/20/2009)..., , NATICK, Mass. and LONDON, Nov. 20 /P...ion (NYSE: BSX ) today announced that it has rec... Administration (FDA) and CE Mark approval to mark...nt for the treatment of malignant esophageal stric...with resectable or non-resectable esophageal cance...
Breaking Medicine Technology:Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4Additive copper zinc interaction affects toxic response in soybean 10674 1Additive copper zinc interaction affects toxic response in soybean 10674 2Stroke Puts Stress on Spousal Relationship 61077 1Stroke Puts Stress on Spousal Relationship 61077 2CenterWatch Honored a Fifth Consecutive Year for Best Healthcare Content 14779 1CenterWatch Honored a Fifth Consecutive Year for Best Healthcare Content 14779 2
...cts Now In Follow-up Period -, EXTON, Pa., Jan. 1...that injections have been completed in the pivotal... placebo-controlled,clinical trials evaluating the...ial folds, or wrinkles (Studies IT-A-005 and IT-A-...od of the study., Isolagen also announced the com...
... Jan. 14 Following an announcement from,Schering-...R),(peginterferon alfa-2a) in combination with rib...s with hepatitis C, in the United States and globa...EAL" study that potentially,favored patients takin...-,particularly the ribavirin dose reduction protoc...
Other Medicine Technology:Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase III Wrinkle and Phase II Full Face Studies 2Roche responds to announcement of 'IDEAL' hepatitis C trial results 2Roche responds to announcement of 'IDEAL' hepatitis C trial results 3Roche responds to announcement of 'IDEAL' hepatitis C trial results 4Roche responds to announcement of 'IDEAL' hepatitis C trial results 5Roche responds to announcement of 'IDEAL' hepatitis C trial results 6Roche responds to announcement of 'IDEAL' hepatitis C trial results 7
(Date:11/21/2009)...9 Test Test Test Test,Te...st Test Test Test Test,Test Test Test Test Test Te...st Test Test Test Test Test Test Test Test Test Te...ore test More test More test More test,More test M...ore test More,test More test , , Please ignore...
(Date:11/21/2009)...ntal Group merges their practice with that of E. S... (PRWEB) November 21, 2009 -- The Ne...vid Gibson, Dr. Dean Cloutier, Dr. John Plachtyna ...wing practice with that of esteemed colleague Dr. ... wanted to retire from dentistry in order to conce...
(Date:11/20/2009)...RNewswire-USNewswire/ -- The United States Confere...ssential changes its health reform bill in order t...d conscience protection on abortion, protect acces... provisions for adequate affordability. ,, The ...rmous disappointment" that creates new and unaccep...
(Date:11/20/2009)...wswire-FirstCall/ -- Centene Corporation (NYSE: ...e Bank of America Merrill Lynch 2009 Credit Confer... Plaza Hotel Times Square in New York City. ,, ...30 a.m. Eastern Time. Investors and other interest...tene,s presentation at: http://www.veracast.com/w...
(Date:11/20/2009)...er 20 in the Journal of the National Cancer Insti...at often appear in news coverage of cancer researc...dia and journals to help alleviate the problem. ,...n, M.D., M.S., of Center for Medicine and the Medi... Clinical Practice in New Hampshire, and Barnett S...
Breaking Medicine News(10 mins):Health News:New Haven Dental Group Expands Their Vision 2Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2
... EXCLUSIVE LAUNCH EVENT TODAY AT RED.MSN.COM , ...RIBUTION VIA ARTIST-TO-FAN SOCIAL NETWORKING , ... , NEW YORK, Dec. 1 Today, World AIDS Day ,...(RED). Throughout the day, visit red.msn.com to ...
... Puerto Rico, Nov. 30 How exposed are your eyes,t...ffects? Do you remember the,date of your next eye ...,professional is located? Find the answers to thes...s in the United States use the Internet for,recrea...
...Nov. 30 /PRNewswire/ - Sentinelle Medical Inc., a ...are, and Toshiba America Medical Systems, Inc. are...inelle,s Vanguard(R) T-Series coil at this year,s ...nt, Toshiba will offer the Sentinelle Vanguard(R) ...
...to air pollution is linked to hardening of the art... -- The decline in highway traffic that was brough... boon to heart health. , That,s because automobile...iculate air pollution with cardiovascular disease ...
... Conn., Nov. 29 FUJIFILM Medical Systems USA is,p...ems, LLC, Morrisville, NC.,Fujifilm has acquired 1... a,wholly owned Fujifilm subsidiary. The acquisiti...ng and health information technology. , "Fuj...
...ov. 28 Colorado,s upcoming statewide,Public Healt...er 1-2, 2008 at,the Marriott Denver West, 1717. Th...ders in public health in Colorado from nearly ever...alth services," said Chris,Wiant, Caring for Color...
Other Medicine News:Health News:World's Greatest Artists Help Launch (RED)WIRE, (RED)(TM)'s New Music Service That Fights AIDS in Africa 2Health News:World's Greatest Artists Help Launch (RED)WIRE, (RED)(TM)'s New Music Service That Fights AIDS in Africa 3Health News:World's Greatest Artists Help Launch (RED)WIRE, (RED)(TM)'s New Music Service That Fights AIDS in Africa 4Health News:World's Greatest Artists Help Launch (RED)WIRE, (RED)(TM)'s New Music Service That Fights AIDS in Africa 5Health News:World's Greatest Artists Help Launch (RED)WIRE, (RED)(TM)'s New Music Service That Fights AIDS in Africa 6Health News:World's Greatest Artists Help Launch (RED)WIRE, (RED)(TM)'s New Music Service That Fights AIDS in Africa 7Health News:Prevention and Eyecare Begin at Home 2Health News:Sentinelle Medical Enters OEM Distribution Agreement with Toshiba 2Health News:Heavy Traffic Can Be Heartbreaking 2Health News:Heavy Traffic Can Be Heartbreaking 3Health News:Fujifilm Acquires Information Systems Vendor Empiric 2Health News:Fujifilm Acquires Information Systems Vendor Empiric 3Health News:Hundreds to Gather for Colorado Public Health Summit 2
Cholesterol Liquid
Cholesterol Reagent
Omega 16ic
... high performance bio imaging system for chemilumi...tes the process of imaging chemiluminescent sample...tremely easy to use, thanks to new, unique image a...Based on the standard Genegnome, the Genegnome HR ...
Medicine Products: